Calycosin ameliorates diabetes-induced cognitive impairments in rats by reducing oxidative stress via the PI3K/Akt/GSK-3β signaling pathway

Biochemical and Biophysical Research Communications

Volumn 473, Issue 2, 2016, Pages 428-434

  Wang, Xiang ^a   Zhao, Linhui ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Calycosin; Cognitive impairments; Oxidant stress; Streptozocin

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CALYCOSIN; GLUTATHIONE PEROXIDASE; GLYCOGEN SYNTHASE KINASE 3BETA; MALONALDEHYDE; PHOSPHATIDYLINOSITOL 3 KINASE; POSTSYNAPTIC DENSITY PROTEIN 95; PROTEIN KINASE B; SUPEROXIDE DISMUTASE; SYNAPSIN; TAU PROTEIN; 7,3'-DIHYDROXY-4'-METHOXYISOFLAVONE; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; HERBACEOUS AGENT; ISOFLAVONE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; COGNITIVE DEFECT; CONTROLLED STUDY; DIABETES MELLITUS; HIPPOCAMPUS; MALE; MORRIS WATER MAZE TEST; MOTOR COORDINATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PASSIVE AVOIDANCE TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SPATIAL LEARNING; SPATIAL MEMORY; ANIMAL; COGNITION DISORDERS; COMPLICATION; DIABETES COMPLICATIONS; DRUG EFFECTS; MAZE TEST; MEMORY; METABOLISM; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; COGNITION DISORDERS; DIABETES COMPLICATIONS; DRUGS, CHINESE HERBAL; GLYCOGEN SYNTHASE KINASE 3; ISOFLAVONES; MALE; MAZE LEARNING; MEMORY; OXIDATIVE STRESS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 84961836242     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2016.03.024     Document Type: Article

References (30)

1. D.R. Whiting, L. Guariguata, C. Weil, and J. Shaw IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030 Diabetes Res. Clin. Pract. 94 2011 311 321
2. L. Velayudhan, M. Poppe, N. Archer, P. Proitsi, R.G. Brown, and S. Lovestone Risk of developing dementia in people with diabetes and mild cognitive impairment Br. J. Psychiatry 196 2010 36 40
3. S.L. Chiu, C.M. Chen, and H.T. Cline Insulin receptor signaling regulates synapse number, dendritic plasticity, and circuit function in vivo Neuron 58 2008 708 719
4. A. Idan-Feldman, Y. Schirer, E. Polyzoidou, O. Touloumi, R. Lagoudaki, N.C. Grigoriadis, and I. Gozes Davunetide (NAP) as a preventative treatment for central nervous system complications in a diabetes rat model Neurobiol. Dis. 44 2011 327 339
5. M.F. Egan, M. Kojima, J.H. Callicott, T.E. Goldberg, B.S. Kolachana, A. Bertolino, E. Zaitsev, B. Gold, D. Goldman, M. Dean, B. Lu, and D.R. Weinberger The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function Cell 112 2003 257 269
6. J. Gunstad, A. Benitez, J. Smith, E. Glickman, M.B. Spitznagel, T. Alexander, J. Juvancic-Heltzel, and L. Murray Serum brain-derived neurotrophic factor is associated with cognitive function in healthy older adults J. Geriatr. Psychiatry Neurol. 21 2008 166 170
7. Q. Liu, F. Xie, R. Rolston, P.I. Moreira, A. Nunomura, X. Zhu, M.A. Smith, and G. Perry Prevention and treatment of Alzheimer disease and aging: antioxidants Mini Rev. Med. Chem. 7 2007 171 180
8. H. Raza, A. John, and F.C. Howarth Increased oxidative stress and mitochondrial dysfunction in zucker diabetic rat liver and brain Cell Physiol. Biochem. 35 2015 1241 1251
9. A.I. Duarte, P. Santos, C.R. Oliveira, M.S. Santos, and A.C. Rego Insulin neuroprotection against oxidative stress is mediated by Akt and GSK-3beta signaling pathways and changes in protein expression Biochim. Biophys. Acta 1783 2008 994 1002
10. C.J. Phiel, C.A. Wilson, V.M. Lee, and P.S. Klein GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides Nature 423 2003 435 439
11. J. Gao, Z.J. Liu, T. Chen, and D. Zhao Pharmaceutical properties of calycosin, the major bioactive isoflavonoid in the dry root extract of Radix astragali Pharm. Biol. 52 2014 1217 1222
12. C. Guo, L. Tong, M. Xi, H. Yang, H. Dong, and A. Wen Neuroprotective effect of calycosin on cerebral ischemia and reperfusion injury in rats J. Ethnopharmacol. 144 2012 768 774
13. R.G. Morris, P. Garrud, J.N. Rawlins, and J. O'Keefe Place navigation impaired in rats with hippocampal lesions Nature 297 1982 681 683
14. S.S. Sharma, S.K. Srinivasan, S. Krishnamoorthy, A.M. Kaushal, and A.K. Bansal Preclinical safety pharmacological studies on the amorphous formulation of celecoxib Arzneimittelforschung 59 2009 254 262
15. C.V. Vorhees, and M.T. Williams Morris water maze: procedures for assessing spatial and related forms of learning and memory Nat. Protoc. 1 2006 848 858
16. G.L. Ellman, K.D. Courtney, V. Andres Jr., and R.M. Feather-Stone A new and rapid colorimetric determination of acetylcholinesterase activity Biochem. Pharmacol. 7 1961 88 95
17. E. Soares, R.D. Prediger, S. Nunes, A.A. Castro, S.D. Viana, C. Lemos, C.M. De Souza, P. Agostinho, R.A. Cunha, E. Carvalho, C.A. Fontes Ribeiro, F. Reis, and F.C. Pereira Spatial memory impairments in a prediabetic rat model Neuroscience 250 2013 565 577
18. W. Jia, W. Gao, and L. Tang Antidiabetic herbal drugs officially approved in China Phytother. Res. 17 2003 1127 1134
19. Y. Xu, J. Xiong, Y. Zhao, B. He, Z. Zheng, G. Chu, and Q. Zhu Calycosin rebalances advanced glycation end products-induced glucose uptake dysfunction of hepatocyte in vitro Am. J. Chin. Med. 43 2015 1191 1210
20. W. Ma, M. Nomura, T. Takahashi-Nishioka, and S. Kobayashi Combined effects of fangchinoline from Stephania tetrandra Radix and formononetin and calycosin from Astragalus membranaceus Radix on hyperglycemia and hypoinsulinemia in streptozotocin-diabetic mice Biol. Pharm. Bull. 30 2007 2079 2083
21. P. Coleman, H. Federoff, and R. Kurlan A focus on the synapse for neuroprotection in Alzheimer disease and other dementias Neurology 63 2004 1155 1162
22. C. Robinet, and L. Pellerin Brain-derived neurotrophic factor enhances the hippocampal expression of key postsynaptic proteins in vivo including the monocarboxylate transporter MCT2 Neuroscience 192 2011 155 163
23. S.S. Kamboj, K. Chopra, and R. Sandhir Neuroprotective effect of N-acetylcysteine in the development of diabetic encephalopathy in streptozotocin-induced diabetes Metab. Brain Dis. 23 2008 427 443
24. C.L. Hawkins, and M.J. Davies Generation and propagation of radical reactions on proteins Biochim. Biophys. Acta 1504 2001 196 219
25. Y. Chen, C.P. Cao, C.R. Li, W. Wang, D. Zhang, L.L. Han, X.Q. Zhang, A. Kim, S. Kim, and G.L. Liu Ghrelin modulates insulin sensitivity and tau phosphorylation in high glucose-induced hippocampal neurons Biol. Pharm. Bull. 33 2010 1165 1169
26. M. Schubert, D.P. Brazil, D.J. Burks, J.A. Kushner, J. Ye, C.L. Flint, J. Farhang-Fallah, P. Dikkes, X.M. Warot, C. Rio, G. Corfas, and M.F. White Insulin receptor substrate-2 deficiency impairs brain growth and promotes tau phosphorylation J. Neurosci. 23 2003 7084 7092
27. L.M. Ittner, Y.D. Ke, F. Delerue, M. Bi, A. Gladbach, J. van Eersel, H. Wolfing, B.C. Chieng, M.J. Christie, I.A. Napier, A. Eckert, M. Staufenbiel, E. Hardeman, and J. Gotz Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models Cell 142 2010 387 397
28. F. Takahashi-Yanaga Activator or inhibitor? GSK-3 as a new drug target Biochem. Pharmacol. 86 2013 191 199
29. B. Clodfelder-Miller, P. De Sarno, A.A. Zmijewska, L. Song, and R.S. Jope Physiological and pathological changes in glucose regulate brain Akt and glycogen synthase kinase-3 J. Biol. Chem. 280 2005 39723 39731
30. M.R. King, N.J. Anderson, L.S. Guernsey, and C.G. Jolivalt Glycogen synthase kinase-3 inhibition prevents learning deficits in diabetic mice J. Neurosci. Res. 91 2013 506 514